APPLICATION
ANDA203988
TYPE
ANDA
ORIGINAL APPROVAL
2015-04-01
LATEST ACTION
2020-10-22
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
SILDENAFIL CITRATEPrescription
SILDENAFIL CITRATE EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2020-10-22Labeling · Supplement 3 · standardAP
2015-11-19Labeling · Supplement 2 · standardAP
2015-04-01UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.